Antimicrobial activity of mast cells: Role and relevance of extracellular DNA traps

Frontiers in Immunology

Volumn 7, Issue JUL, 2016, Pages

  Möllerherm, Helene ^a   von Köckritz Blickwede, Maren ^a   Branitzki Heinemann, Katja ^a  

^a UNIVERSITY OF VETERINARY MEDICINE HANNOVER   (Germany)

Author keywords

Antimicrobial activity; Degranulation; Extracellular traps; Innate immunity; Mast cell; MCET; Neutrophil; Phagocytosis

Indexed keywords

CATHELICIDIN; HYPOXIA INDUCIBLE FACTOR 1ALPHA; INTERFERON; INTERLEUKIN 8; REACTIVE OXYGEN METABOLITE; TUMOR NECROSIS FACTOR ALPHA;

ANTIMICROBIAL ACTIVITY; BACTERIAL INFECTION; CANDIDA ALBICANS; EXTRACELLULAR TRAP; HUMAN; IMMUNE RESPONSE; INFLAMMATION; INTERNALIZATION; MAST CELL; NEUTROPHIL; NONHUMAN; PHAGOCYTOSIS; SHORT SURVEY; STREPTOCOCCUS PYOGENES; TRANSMISSION ELECTRON MICROSCOPY;

EID: 84983348004     PISSN: None     EISSN: 16643224     Source Type: Journal    
DOI: 10.3389/fimmu.2016.00265     Document Type: Short Survey

References (60)

1. Stanworth DR. The discovery of IgE. Allergy (1993) 48:67-71. doi:10.1111/j.1398-9995.1993.tb00687.x
2. Galli SJ, Tsai M. Mast cells in allergy and infection: versatile effector and regulatory cells in innate and adaptive immunity. Eur J Immunol (2010) 40:1843-51. doi:10.1002/eji.201040559
3. da Silva EZ, Jamur MC, Oliver C. Mast cell function: a new vision of an old cell. J Histochem Cytochem (2014) 62(10):698-738. doi:10.1369/0022155414545334
4. Puxeddu I, Piliponsky AM, Bachelet I, Levi-Schaffer F. Mast cells in allergy and beyond. Int J Biochem Cell Biol (2003) 35:1601-7. doi:10.1016/S1357-2725(03)00208-5
5. Marshall JS. Mast-cell responses to pathogens. Nat Rev Immunol (2004) 4(10):787-99. doi:10.1038/nri1460
6. Urb M, Sheppard DC. The role of mast cells in the defence against pathogens. PLoS Pathog (2012) 8(4):e1002619. doi:10.1371/journal.ppat.1002619
7. Arock M, Ross E, Lai-Kuen R, Averlant G, Gao Z, Abraham SN. Phagocytic and tumor necrosis factor alpha response of human mast cells following exposure to gram-negative and gram-positive bacteria. Infect Immun (1998) 66:6030-4.
8. Branitzki-Heinemann K, Okumura CY, Völlger L, Kawakami Y, Kawakami T, Naim HY, et al. Novel role of the transcription factor HIF-1a in the formation of mast cell extracellular traps. Biochem J (2012) 446(1):159-63. doi:10.1042/BJ20120658
9. von Köckritz-Blickwede M, Goldmann O, Thulin P, Heinemann K, Norrby-Teglund A, Rohde M, et al. Phagocytosis independent antimicrobial activity of mast cells by means of extracellular trap formation. Blood (2008) 111:3070-80. doi:10.1182/blood-2007-07-104018
10. Rocha-de-Souza CM, Berent-Maoz B, Mankuta D, Moses AE, Levi-Schaffer F. Human mast cell activation by Staphylococcus aureus: interleukin-8 and tumor necrosis factor alpha release and the role of toll-like receptor 2 and CD48 molecules. Infect Immun (2008) 76(10):4489-97. doi:10.1128/IAI.00270-08
11. Lauth X, von Köckritz-Blickwede M, McNamara CW, Myskowski S, Zinkernagel AS, Beall B, et al. M1 protein allows group A streptococcal survival in phagocyte extracellular traps through cathelicidin inhibition. J Innate Immun (2009) 1(3):202-14. doi:10.1159/000203645
12. Siebenhaar F, Syska W, Weller K, Magerl M, Zuberbier T, Metz M, et al. Control of Pseudomonas aeruginosa skin infections in mice is mast cell-dependent. Am J Pathol (2007) 170:1-7. doi:10.2353/ajpath.2007.060770
13. Malaviya R, Ikeda T, Ross E, Abraham SN. Mast cell modulation of neutrophil influx and bacterial clearance at sites of infection through TNF-alpha. Nature (1996) 381:77-80. doi:10.1038/381077a0
14. Wei OL, Hilliard A, Kalman D, Sherman M. Mast cells limit systemic bacterial dissemination but not colitis in response to Citrobacter rodentium. Infect Immun (2005) 73:1978-85. doi:10.1128/IAI.73.4.1978-1985.2005
15. Scheb-Wetzel M, Rohde M, Bravo A, Goldmann O. New insights into the antimicrobial effect of mast cells against Enterococcus faecalis. Infect Immun (2014) 82(11):4496. doi:10.1128/IAI.02114-14
16. Lopes J, Stylianou M, Nilsson G, Urban CF. Opportunistic pathogen Candida albicans elicits a temporal response in primary human mast cells. Sci Rep (2015) 5:12287. doi:10.1038/srep12287
17. Dietrich N, Rohde M, Geffers R, Kröger A, Hauser H, Weiss S, et al. Mast cells elicit proinflammatory but not type I interferon responses upon activation of TLRs by bacteria. Proc Natl Acad Sci U S A (2010) 107(19):8748-53. doi:10.1073/pnas.0912551107
18. Thrasher SM, Scalfone LK, Holowka D, Appleton JA. In vitro modelling of rat mucosal mast cell function in Trichinella spiralis infection. Parasite Immunol (2013) 35(1):21-31. doi:10.1111/pim.12014
19. Romão PR, Da Costa Santiago H, Ramos CD, De Oliveira CF, Monteiro MC, De Queiroz Cunha F, et al. Mast cell degranulation contributes to susceptibility to Leishmania major. Parasite Immunol (2009) 31(3):140-6. doi:10.1111/j.1365-3024.2008.01084.x
20. de Bernard M, Cappon A, Pancotto L, Ruggiero P, Rivera J, Del Giudice G, et al. The Helicobacter pylori VacA cytotoxin activates RBL-2H3 cells by inducing cytosolic calcium oscillations. Cell Microbiol (2005) 7:191-8. doi:10.1111/j.1462-5822.2004.00446.x
21. Gurish MF, Boyce JA. Mast cells: ontogeny, homing, and recruitment of a unique innate effector cell. J Allergy Clin Immunol (2006) 117(6):1285-91. doi:10.1016/j.jaci.2006.04.017
22. Metcalfe DD, Baram D, Mekori YA. Mast cells. Physiol Rev (1997) 77:1033-79.
23. Balseiro-Gomez S, Ramirez-Ponce MP, Acosta J, Ales E, Flores JA. Intestinal and peritoneal mast cells differ in kinetics of quantal release. Biochem Biophys Res Commun (2016) 469(3):559-64. doi:10.1016/j.bbrc.2015.12.033
24. Abraham SN, St John AS. Mast cell-orchestrated immunity to pathogens. Nat Rev Immunol (2010) 10(6):440-52. doi:10.1038/nri2782
25. Collington SJ, Williams TJ, Weller CL. Mechanisms underlying the localisation of mast cells in tissues. Trends Immunol (2011) 32(10):478-85. doi:10.1016/j.it.2011.08.002
26. Weller CL, Collington SJ, Williams T, Lamb JR. Mast cells in health and disease. Clin Sci (Lond) (2011) 120:473-84. doi:10.1042/CS20100459
27. Mekori YA, Metcalfe DD. Mast cells in innate immunity. Immunol Rev (2000) 73:131-40. doi:10.1034/j.1600-065X.2000.917305.x
28. Gordon JR, Galli SJ. Mast cells as a source of both preformed and immunologically inducible TNF-alpha/cachectin. Nature (1990) 346:274-8. doi:10.1038/346274a0
29. Nakamura Y, Oscherwitz J, Cease KB, Chan SM, Muñoz-Planillo R, Hasegawa M, et al. Staphylococcus d-toxin induces allergic skin disease by activating mast cells. Nature (2013) 503(7476):397-401. doi:10.1038/nature12655
30. Oscherwitz J, Cease KB, Chan SM, Muñoz-Planillo R, Hasegawa M, Villaruz AE, et al. Staphylococcus d-toxin promotes mouse allergic skin disease by inducing mast cell degranulation. Nature (2013) 503(7476):397-401. doi:10.1038/nature12655
31. Di Nardo A, Vitiello A, Gallo RL. Cutting edge: mast cell antimicrobial activity is mediated by expression of cathelicidin antimicrobial peptide. J Immunol (2003) 170:2274-8. doi:10.4049/jimmunol.170.5.2274
32. Di Nardo A, Yamasaki K, Dorschner RA, Lai Y, Gallo RL. Mast cell cathelicidin antimicrobial peptide prevents invasive group A Streptococcus infection of the skin. J Immunol (2008) 180(11):7565-73. doi:10.4049/jimmunol.180.11.7565
33. Féger F, Varadaradjalou S, Gao Z, Abraham SN, Arock M. The role of mast cells in host defense and their subversion by bacterial pathogens. Trends Immunol (2002) 23:151-7. doi:10.1016/S1471-4906(01)02156-1
34. Abel J, Goldmann O, Ziegler C, Höltje C, Smeltzer MS, Cheung AL, et al. Staphylococcus aureus evades the extracellular antimicrobial activity of mast cells by promoting its own uptake. J Innate Immun (2011) 3(5):495-507. doi:10.1159/000327714
35. Goldmann O, Tuchscherr L, Rohde M, Medina E. a-hemolysin enhances Staphylococcus aureus internalization and survival within mast cells by modulating the expression of β1 integrin. Cell Microbiol (2016) 18(6):807-19. doi:10.1111/cmi.12550
36. Dean SN, Bishop BM, van Hoek ML. Natural and synthetic cathelicidin peptides with anti-microbial and anti-biofilm activity against Staphylococcus aureus. BMC Microbiol (2011) 11:114. doi:10.1186/1471-2180-11-114
37. Trotter CM, Carney AS, Wilson JA. Mast cell distribution and morphology in human nasal turbinates following decalcification. Rhinology (1989) 27(2):81-9.
38. Fuchs TA, Abed U, Goosmann C, Hurwitz R, Schulze I, Wahn V, et al. Novel cell death program leads to neutrophil extracellular traps. J Cell Biol (2007) 176:231-41. doi:10.1083/jcb.200606027
39. Wartha F, Henriques-Normark B. ETosis: a novel cell death pathway. Sci Signal (2008) 1(21):e25. doi:10.1126/stke.121pe25
40. Brinkmann V, Reichard U, Goosmann C, Fauler B, Uhlemann Y, Weiss DS, et al. Neutrophil extracellular traps kill bacteria. Science (2004) 303:1532-5. doi:10.1126/science.1092385
41. Neumann A, Berends ET, Nerlich A, Molhoek EM, Gallo RL, Meerloo T, et al. The antimicrobial peptide LL-37 facilitates the formation of neutrophil extracellular traps. Biochem J (2014) 464(1):3-11. doi:10.1042/BJ20140778
42. Lin AM, Rubin CJ, Khandpur R, Wang JY, Riblett M, Yalavarthi S, et al. Mast cells and neutrophils release IL-17 through extracellular trap formation in psoriasis. J Immunol (2011) 187(1):490-500. doi:10.4049/jimmunol.1100123
43. Peyssonnaux C, Datta V, Cramer T, Doedens A, Theodorakis EA, Gallo RL, et al. HIF-1alpha expression regulates the bactericidal capacity of phagocytes. J Clin Invest (2005) 115(7):1806-15. doi:10.1172/JCI23865
44. Zinkernagel AS, Johnson RS, Nizet V. Hypoxia inducible factor (HIF) function in innate immunity and infection. J Mol Med (Berl) (2007) 85(12):1339-46. doi:10.1007/s00109-007-0282-2
45. Imtiyaz HZ, Simon MC. Hypoxia-inducible factors as essential regulators of inflammation. Curr Top Microbiol Immunol (2010) 345:105-20. doi:10.1007/82_2010_74
46. Rius J, Guma M, Schachtrup C, Akassoglou K, Zinkernagel AS, Nizet V, et al. NF-kB links innate immunity to the hypoxic response through transcriptional regulation of HIF-1alpha. Nature (2008) 453:807-11. doi:10.1038/nature06905
47. Palazon A, Goldrath A, Nizet V, Johnson RS. HIF transcription factors, inflammation, and immunity. Immunity (2014) 41(4):518-28. doi:10.1016/j.immuni.2014.09.008
48. Zinkernagel AS, Peyssonnaux C, Johnson RS, Nizet V. Pharmacologic augmentation of hypoxia-inducible factor-1alpha with mimosine boosts the bactericidal capacity of phagocytes. J Infect Dis (2008) 197(2):214-7. doi:10.1086/524843
49. Völlger L, Akong-Moore KA, Cox L, Goldmann O, Wang Y, Schäfer S, et al. Iron chelating agent desferrioxamine stimulates formation of neutrophil extracellular traps (NETs) in human blood-derived neutrophils. Biosci Rep (2016) 36(3):e00333. doi:10.1042/BSR20160031
50. McInturff AM, Cody MJ, Elliott EA, Glenn JW, Rowley JW, Rondina MT, et al. Mammalian target of rapamycin regulates neutrophil extracellular trap formation via induction of hypoxia-inducible factor 1 a. Blood (2012) 120(15):3118-25. doi:10.1182/blood-2012-01-405993
51. Papayannopoulos V, Metzler KD, Hakkim A, Zychlinsky A. Neutrophil elastase and myeloperoxidase regulate the formation of neutrophil extracellular traps. J Cell Biol (2010) 191(3):677-91. doi:10.1083/jcb.201006052
52. Parker H, Albrett AM, Kettle AJ, Winterbourn CC. Myeloperoxidase associated with neutrophil extracellular traps is active and mediates bacterial killing in the presence of hydrogen peroxide. J Leukoc Biol (2012) 91(3):369-76. doi:10.1189/jlb.0711387
53. Jordan JH, Walchshofer S, Jurecka W, Mosberger I, Sperr WR, Wolff K, et al. Immunohistochemical properties of bone marrow mast cells in systemic mastocytosis: evidence for expression of CD2, CD117/Kit, and bcl-x(L). Hum Pathol (2001) 32(5):545-52. doi:10.1053/hupa.2001.24319
54. Yousefi S, Mihalache C, Kozlowski E, Schmid I, Simon HU. Viable neutrophils release mitochondrial DNA to form neutrophil extracellular traps. Cell Death Differ (2009) 16:1438-44. doi:10.1038/cdd.2009.96
55. Yipp BG, Petri B, Salina D, Jenne CN, Scott BN, Zbytnuik LD, et al. Infection-induced NETosis is a dynamic process involving neutrophil multitasking in vivo. Nat Med (2012) 18:1386-93. doi:10.1038/nm.2847
56. Yousefi S, Gold JA, Andina N, Lee JJ, Kelly AM, Kozlowski E, et al. Catapult-like release of mitochondrial DNA by eosinophils contributes to antibacterial defense. Nat Med (2008) 14(9):949-53. doi:10.1038/nm.1855
57. Yousefi S, Morshed M, Amini P, Stojkov D, Simon D, von Gunten S, et al. Basophils exhibit antibacterial activity through extracellular trap formation. Allergy (2015) 70(9):1184-8. doi:10.1111/all.12662
58. Schauer C, Janko C, Munoz LE, Zhao Y, Kienhöfer D, Frey B, et al. Aggregated neutrophil extracellular traps limit inflammation by degrading cytokines and chemokines. Nat Med (2014) 20(5):511-7. doi:10.1038/nm.3547
59. Brown MA, Hatfield JK. Mast cells are important modifiers of autoimmune disease: with so much evidence, why is there still controversy? Front Immunol (2012) 3:147. doi:10.3389/fimmu.2012.00147
60. Undem BJ, Taylor-Clark T. Mechanisms underlying the neuronal-based symptoms of allergy. J Allergy Clin Immunol (2014) 133(6):1521-34. doi:10.1016/j.jaci.2013.11.027